$AMPH
Amphastar Pharmaceuticals, Inc.

2023 Q3 Form 10-Q Financial Statement

#000129718423000066 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $180.6M $145.7M
YoY Change 50.3% 18.02%
Cost Of Revenue $72.15M $72.97M
YoY Change 17.1% 21.4%
Gross Profit $108.4M $72.74M
YoY Change 85.27% 14.81%
Gross Profit Margin 60.04% 49.92%
Selling, General & Admin $19.06M $19.00M
YoY Change 13.67% 20.74%
% of Gross Profit 17.58% 26.12%
Research & Development $16.66M $16.84M
YoY Change -9.99% -26.12%
% of Gross Profit 15.37% 23.16%
Depreciation & Amortization $9.619M $3.063M
YoY Change 181.18% 2.24%
% of Gross Profit 8.87% 4.21%
Operating Expenses $35.73M $35.84M
YoY Change 1.26% -6.98%
Operating Profit $72.68M $36.90M
YoY Change 212.89% 48.64%
Interest Expense $13.70M $3.602M
YoY Change 2320.85% 807.3%
% of Operating Profit 18.85% 9.76%
Other Income/Expense, Net -$9.041M -$4.088M
YoY Change 1330.54% 144.5%
Pretax Income $63.64M $32.81M
YoY Change 181.63% 41.71%
Income Tax $14.03M $6.383M
% Of Pretax Income 22.04% 19.46%
Net Earnings $49.22M $26.12M
YoY Change 210.08% 50.61%
Net Earnings / Revenue 27.26% 17.93%
Basic Earnings Per Share $1.01 $0.54
Diluted Earnings Per Share $0.91 $0.49
COMMON SHARES
Basic Shares Outstanding 48.86M 48.27M
Diluted Shares Outstanding 53.92M 53.10M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $299.9M $163.1M
YoY Change 62.91% -11.04%
Cash & Equivalents $266.8M $148.6M
Short-Term Investments $33.10M $14.54M
Other Short-Term Assets $12.70M $10.76M
YoY Change 50.81% 29.09%
Inventory $110.0M $104.6M
Prepaid Expenses
Receivables $119.0M $104.7M
Other Receivables $1.500M $1.329M
Total Short-Term Assets $543.0M $384.6M
YoY Change 41.33% 1.96%
LONG-TERM ASSETS
Property, Plant & Equipment $280.8M $305.5M
YoY Change 20.66% 28.6%
Goodwill $3.092M $3.165M
YoY Change 7.14% 3.63%
Intangibles
YoY Change
Long-Term Investments $2.000M $1.462M
YoY Change -25.65% -52.3%
Other Assets $25.30M $61.14M
YoY Change 23.12% 227.23%
Total Long-Term Assets $1.002B $993.7M
YoY Change 192.47% 186.72%
TOTAL ASSETS
Total Short-Term Assets $543.0M $384.6M
Total Long-Term Assets $1.002B $993.7M
Total Assets $1.545B $1.378B
YoY Change 112.56% 90.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.97M $217.5M
YoY Change 60.15% 600.13%
Accrued Expenses $190.7M $3.133M
YoY Change 151.54% -95.3%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $400.0K $12.92M
YoY Change -76.19% 528.1%
Total Short-Term Liabilities $258.0M $251.3M
YoY Change 152.43% 142.47%
LONG-TERM LIABILITIES
Long-Term Debt $653.3M $488.3M
YoY Change 782.66% 560.99%
Other Long-Term Liabilities $15.70M $49.27M
YoY Change 10.63% 221.32%
Total Long-Term Liabilities $669.0M $537.5M
YoY Change 4614.36% 3406.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $258.0M $251.3M
Total Long-Term Liabilities $669.0M $537.5M
Total Liabilities $949.5M $789.0M
YoY Change 328.61% 251.6%
SHAREHOLDERS EQUITY
Retained Earnings $373.1M $323.9M
YoY Change 56.89% 45.93%
Common Stock $6.000K $6.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $247.4M $197.4M
YoY Change 44.31% 25.78%
Treasury Stock Shares
Shareholders Equity $595.1M $589.2M
YoY Change
Total Liabilities & Shareholders Equity $1.545B $1.378B
YoY Change 112.56% 90.44%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $49.22M $26.12M
YoY Change 210.08% 50.61%
Depreciation, Depletion And Amortization $9.619M $3.063M
YoY Change 181.18% 2.24%
Cash From Operating Activities $64.30M $54.92M
YoY Change 215.58% 1851.08%
INVESTING ACTIVITIES
Capital Expenditures $10.20M $9.054M
YoY Change -281.4% -251.86%
Acquisitions
YoY Change
Other Investing Activities -$20.90M -$499.5M
YoY Change 116.92% 22421.55%
Cash From Investing Activities -$31.20M -$508.6M
YoY Change 104.48% 6117.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 86.60M 428.1M
YoY Change -721.64% -43169.52%
NET CHANGE
Cash From Operating Activities 64.30M 54.92M
Cash From Investing Activities -31.20M -508.6M
Cash From Financing Activities 86.60M 428.1M
Net Change In Cash 119.7M -25.55M
YoY Change -1458.07% 301.76%
FREE CASH FLOW
Cash From Operating Activities $64.30M $54.92M
Capital Expenditures $10.20M $9.054M
Free Cash Flow $54.10M $45.87M
YoY Change 108.09% 422.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2021Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
us-gaap Pension Expense
PensionExpense
0
CY2022Q2 us-gaap Pension Expense
PensionExpense
0
us-gaap Pension Expense
PensionExpense
0
CY2023Q2 us-gaap Pension Expense
PensionExpense
0
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Registrant Name
EntityRegistrantName
Amphastar Pharmaceuticals, Inc.
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001297184
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Shell Company
EntityShellCompany
false
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Document Transition Report
DocumentTransitionReport
false
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023Q2 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
0
dei Document Type
DocumentType
10-Q
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Entity File Number
EntityFileNumber
001-36509
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0702205
dei Entity Address Address Line1
EntityAddressAddressLine1
11570 6th Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Rancho Cucamonga
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91730
dei City Area Code
CityAreaCode
909
dei Local Phone Number
LocalPhoneNumber
980-9484
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
AMPH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48855602
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
148595000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156098000
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
2685000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
235000
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
14541000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
19664000
CY2023Q2 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
2200000
CY2022Q4 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
2200000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
104715000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
88804000
CY2023Q2 us-gaap Inventory Net
InventoryNet
104617000
CY2022Q4 us-gaap Inventory Net
InventoryNet
103584000
CY2023Q2 amph Income Tax Refund And Deposits
IncomeTaxRefundAndDeposits
1329000
CY2022Q4 amph Income Tax Refund And Deposits
IncomeTaxRefundAndDeposits
171000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5872000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7563000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
384554000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
378319000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
278526000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
238266000
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
657000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
753000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26327000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25554000
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
1462000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
2414000
CY2023Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
625603000
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
37298000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20269000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20856000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
40868000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
38527000
CY2023Q2 us-gaap Assets
Assets
1378266000
CY2022Q4 us-gaap Assets
Assets
741987000
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
217536000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
84242000
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
17696000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4571000
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
12920000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3046000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3133000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3003000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
251285000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
94862000
CY2023Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
7225000
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
7225000
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
488280000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
72839000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24407000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23694000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
201000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
144000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17633000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14565000
CY2023Q2 us-gaap Liabilities
Liabilities
789031000
CY2022Q4 us-gaap Liabilities
Liabilities
213329000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59068477
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48818806
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58110231
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48112069
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
6000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
6000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
471110000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
455077000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
323880000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
271723000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8324000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8624000
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
197437000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
189524000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
589235000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
528658000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1378266000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
741987000
CY2023Q2 us-gaap Revenues
Revenues
145712000
CY2022Q2 us-gaap Revenues
Revenues
123467000
us-gaap Revenues
Revenues
285734000
us-gaap Revenues
Revenues
243835000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
72974000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
60111000
us-gaap Cost Of Revenue
CostOfRevenue
139156000
us-gaap Cost Of Revenue
CostOfRevenue
124653000
CY2023Q2 us-gaap Gross Profit
GrossProfit
72738000
CY2022Q2 us-gaap Gross Profit
GrossProfit
63356000
us-gaap Gross Profit
GrossProfit
146578000
us-gaap Gross Profit
GrossProfit
119182000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6718000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5756000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13827000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11275000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12281000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9979000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25764000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22449000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16843000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22798000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36658000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39021000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
35842000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
38533000
us-gaap Operating Expenses
OperatingExpenses
76249000
us-gaap Operating Expenses
OperatingExpenses
72745000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
36896000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
24823000
us-gaap Operating Income Loss
OperatingIncomeLoss
70329000
us-gaap Operating Income Loss
OperatingIncomeLoss
46437000
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1030000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
229000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1954000
us-gaap Investment Income Interest
InvestmentIncomeInterest
410000
CY2023Q2 us-gaap Interest Expense
InterestExpense
3602000
CY2022Q2 us-gaap Interest Expense
InterestExpense
397000
us-gaap Interest Expense
InterestExpense
4000000
us-gaap Interest Expense
InterestExpense
752000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1516000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1504000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1906000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6089000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4088000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1672000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3952000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5747000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32808000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23151000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
66377000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
52184000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6383000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5551000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13135000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9628000
CY2023Q2 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
26425000
CY2022Q2 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
17600000
amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
53242000
amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
42556000
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-301000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-254000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1086000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-957000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
26124000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
17346000
us-gaap Net Income Loss
NetIncomeLoss
52156000
us-gaap Net Income Loss
NetIncomeLoss
41599000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.99
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48404000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48864000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48202000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48501000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53102000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53227000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52536000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52603000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
26124000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
17346000
us-gaap Net Income Loss
NetIncomeLoss
52156000
us-gaap Net Income Loss
NetIncomeLoss
41599000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-56000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1464000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
300000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1944000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-56000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1464000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
300000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1944000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26068000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15882000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
52456000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39655000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
528658000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26032000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
356000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8015000
CY2023Q1 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
-4565000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6111000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8623000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
548577000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
26124000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-56000
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
129000
CY2023Q2 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
9853000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4865000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
589235000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
445522000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
24253000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-480000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1229000
CY2022Q1 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
6437000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5022000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
479525000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
17346000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1464000
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
6118000
CY2022Q2 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
5783000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4235000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
499307000
us-gaap Profit Loss
ProfitLoss
52156000
us-gaap Profit Loss
ProfitLoss
41599000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-7000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
58000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
2700000
amph Gain Loss On Interest Rate Swaps And Foreign Currency Transactions Net
GainLossOnInterestRateSwapsAndForeignCurrencyTransactionsNet
-2434000
amph Gain Loss On Interest Rate Swaps And Foreign Currency Transactions Net
GainLossOnInterestRateSwapsAndForeignCurrencyTransactionsNet
298000
us-gaap Depreciation
Depreciation
12121000
us-gaap Depreciation
Depreciation
11411000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
471000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
504000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1825000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1709000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3249000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
192000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1086000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-957000
us-gaap Share Based Compensation
ShareBasedCompensation
10976000
us-gaap Share Based Compensation
ShareBasedCompensation
9257000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10533000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2178000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
767000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7422000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-740000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-468000
amph Increase Decrease In Income Tax Refund Deposits And Payable
IncreaseDecreaseInIncomeTaxRefundDepositsAndPayable
-11967000
amph Increase Decrease In Income Tax Refund Deposits And Payable
IncreaseDecreaseInIncomeTaxRefundDepositsAndPayable
14235000
amph Operating Lease Right Of Use Assets And Liabilities Net
OperatingLeaseRightOfUseAssetsAndLiabilitiesNet
-1750000
amph Operating Lease Right Of Use Assets And Liabilities Net
OperatingLeaseRightOfUseAssetsAndLiabilitiesNet
-1468000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13142000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
95305000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
53580000
amph Payments Acquisitions Of Assets
PaymentsAcquisitionsOfAssets
500829000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18531000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12101000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
421000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
19774000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
12004000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
25151000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
6391000
amph Payments For Deposits And Other Assets
PaymentsForDepositsAndOtherAssets
932000
amph Payments For Deposits And Other Assets
PaymentsForDepositsAndOtherAssets
-3000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-514915000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17290000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
5288000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
12220000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8143000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7346000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
14150000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
89000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
500000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
68432000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1131000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
414563000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3654000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-6000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-140000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5053000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
39804000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
156333000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126588000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151280000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
166392000
amph Deferred Payment For Acquisition
DeferredPaymentForAcquisition
127276000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3681000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5539000
amph Noncash Operating Lease Right Of Use Asset
NoncashOperatingLeaseRightOfUseAsset
2598000
amph Noncash Operating Lease Right Of Use Asset
NoncashOperatingLeaseRightOfUseAsset
1777000
us-gaap Interest Paid Net
InterestPaidNet
2772000
us-gaap Interest Paid Net
InterestPaidNet
1167000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1322000
us-gaap Income Taxes Paid
IncomeTaxesPaid
23964000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Use of Estimates</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;margin-bottom:14pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. The principal accounting estimates include: fair value of acquired assets, determination of allowances for credit losses, fair value of financial instruments, allowance for discounts, provision for chargebacks and rebates, provision for product returns, adjustment of inventory to its net realizable value, impairment of investments, long-lived and intangible assets and goodwill, accrual for workers’ compensation liabilities, litigation reserves, stock price volatility for share-based compensation expense, valuation allowances for deferred tax assets, and liabilities for uncertain income tax positions.</p>
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-100000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
500000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2100000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2700000
CY2022Q4 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
200000
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
2700000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2023Q2 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
2200000
CY2022Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
2200000
CY2022Q4 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
26606000
CY2021Q4 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
20167000
amph Revenue Recognition Wholesaler Chargebacks Provision Related To Sales In Period
RevenueRecognitionWholesalerChargebacksProvisionRelatedToSalesInPeriod
143792000
amph Revenue Recognition Wholesaler Chargebacks Provision Related To Sales In Period
RevenueRecognitionWholesalerChargebacksProvisionRelatedToSalesInPeriod
96593000
amph Revenue Recognition Wholesaler Chargebacks Credits Issued To Third Parties
RevenueRecognitionWholesalerChargebacksCreditsIssuedToThirdParties
141584000
amph Revenue Recognition Wholesaler Chargebacks Credits Issued To Third Parties
RevenueRecognitionWholesalerChargebacksCreditsIssuedToThirdParties
94526000
CY2023Q2 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
28814000
CY2022Q2 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
22234000
CY2023Q2 amph Product Return Accrual Current
ProductReturnAccrualCurrent
13800000
CY2022Q4 amph Product Return Accrual Current
ProductReturnAccrualCurrent
14900000
CY2023Q2 amph Product Return Accrual Non Current
ProductReturnAccrualNonCurrent
5000000.0
CY2022Q4 amph Product Return Accrual Non Current
ProductReturnAccrualNonCurrent
4600000
amph Product Return Rate Percentage
ProductReturnRatePercentage
0.012
amph Product Return Rate Percentage
ProductReturnRatePercentage
0.016
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
26124000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
17346000
us-gaap Net Income Loss
NetIncomeLoss
52156000
us-gaap Net Income Loss
NetIncomeLoss
41599000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48404000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48864000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48202000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48501000
CY2023Q2 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
4698000
CY2022Q2 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
4363000
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
4334000
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
4102000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53102000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53227000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52536000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52603000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.99
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q2 us-gaap Revenues
Revenues
145712000
CY2022Q2 us-gaap Revenues
Revenues
123467000
us-gaap Revenues
Revenues
285734000
us-gaap Revenues
Revenues
243835000
CY2023Q2 us-gaap Gross Profit
GrossProfit
72738000
CY2022Q2 us-gaap Gross Profit
GrossProfit
63356000
us-gaap Gross Profit
GrossProfit
146578000
us-gaap Gross Profit
GrossProfit
119182000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
35842000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
38533000
us-gaap Operating Expenses
OperatingExpenses
76249000
us-gaap Operating Expenses
OperatingExpenses
72745000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
36896000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
24823000
us-gaap Operating Income Loss
OperatingIncomeLoss
70329000
us-gaap Operating Income Loss
OperatingIncomeLoss
46437000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4088000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1672000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3952000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5747000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32808000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23151000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
66377000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
52184000
CY2023Q2 amph Indefinite Lived Intangible Assets Including Goodwill Net
IndefiniteLivedIntangibleAssetsIncludingGoodwillNet
32390000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3063000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2996000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6462000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5738000
CY2023Q2 us-gaap Revenues
Revenues
145712000
CY2022Q2 us-gaap Revenues
Revenues
123467000
us-gaap Revenues
Revenues
285734000
us-gaap Revenues
Revenues
243835000
CY2023Q2 us-gaap Noncurrent Assets
NoncurrentAssets
896848000
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
264573000
CY2023Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
14444000
CY2023Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
11000
CY2023Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
14433000
CY2022Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
23515000
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
62000
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
23453000
CY2023Q2 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P23Y
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
602826000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9613000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
593213000
CY2023Q2 amph Indefinite Lived Intangible Assets Including Goodwill Gross
IndefiniteLivedIntangibleAssetsIncludingGoodwillGross
32390000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
790000
CY2023Q2 us-gaap Contractual Obligation
ContractualObligation
509008000
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
77432000
CY2023Q2 amph Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
635216000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9613000
CY2023Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
625603000
CY2022Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P11Y
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11488000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6541000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4947000
CY2022Q4 amph Indefinite Lived Intangible Assets Including Goodwill Gross
IndefiniteLivedIntangibleAssetsIncludingGoodwillGross
32351000
CY2022Q4 amph Indefinite Lived Intangible Assets Including Goodwill Net
IndefiniteLivedIntangibleAssetsIncludingGoodwillNet
32351000
CY2022Q4 amph Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
43839000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6541000
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
37298000
CY2022Q4 us-gaap Goodwill
Goodwill
3126000
CY2021Q4 us-gaap Goodwill
Goodwill
3313000
us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
39000
CY2022 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-187000
CY2023Q2 us-gaap Goodwill
Goodwill
3165000
CY2022Q4 us-gaap Goodwill
Goodwill
3126000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
12359000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
24718000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
24718000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
24718000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
24718000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
481982000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
593213000
CY2023Q2 amph Indefinite Lived Intangible Assets Including Goodwill
IndefiniteLivedIntangibleAssetsIncludingGoodwill
32390000
CY2023Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
625603000
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
12920000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3046000
CY2023Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
44630000
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
47607000
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
31771000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
37090000
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
28216000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
18887000
CY2023Q2 us-gaap Inventory Net
InventoryNet
104617000
CY2022Q4 us-gaap Inventory Net
InventoryNet
103584000
CY2023Q2 us-gaap Inventory Write Down
InventoryWriteDown
8300000
us-gaap Inventory Write Down
InventoryWriteDown
10200000
CY2022Q2 us-gaap Inventory Write Down
InventoryWriteDown
600000
us-gaap Inventory Write Down
InventoryWriteDown
8600000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
198704000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
63741000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
18832000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
20501000
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
217536000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
84242000
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
692000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
510877000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
458296000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
232351000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
220030000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
278526000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
238266000
CY2023Q2 amph Accrued Customer Fees And Rebates
AccruedCustomerFeesAndRebates
17764000
CY2022Q4 amph Accrued Customer Fees And Rebates
AccruedCustomerFeesAndRebates
14198000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
24912000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22847000
CY2023Q2 amph Product Return Accrual Current
ProductReturnAccrualCurrent
13845000
CY2022Q4 amph Product Return Accrual Current
ProductReturnAccrualCurrent
14867000
CY2023Q2 amph Accrued Loss On Firm Purchase Commitments
AccruedLossOnFirmPurchaseCommitments
5187000
CY2022Q4 amph Accrued Loss On Firm Purchase Commitments
AccruedLossOnFirmPurchaseCommitments
2686000
CY2023Q2 amph Accrued Payments For Asset Acquisitions
AccruedPaymentsForAssetAcquisitions
126760000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10236000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9143000
CY2023Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
7808000
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
1547000
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
488280000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
72839000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32808000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23151000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
66377000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
52184000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6383000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5551000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13135000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9628000
CY2023Q2 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
26425000
CY2022Q2 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
17600000
amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
53242000
amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
42556000
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.195
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.240
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.198
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.185
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.402
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.405
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.414
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.410
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.038
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.030
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.041
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.023
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y10M24D
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7929150
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.66
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
759350
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
35.83
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
642019
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
15.22
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4526
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
29.60
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
500
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
14.66
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8041455
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.57
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
304777000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5945056
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
16.51
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y9M10D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
243537000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
7814400
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
19.27
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y10M28D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
298513000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.77
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.13
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.76
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.75
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
16575000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6510000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
18916000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
18710000
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8350000
CY2022Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4469000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9738000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16919000
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1136000
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1004000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
8720000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
7990000
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2378453
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
9.48
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
759350
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.76
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1036878
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
8.41
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
4526
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
13.40
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2096399
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
12.64
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4865000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4235000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10976000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9257000
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06
CY2023Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
600000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1200000
CY2022Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
500000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1100000
CY2023Q2 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.038
CY2022Q4 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.038
CY2023Q2 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
2300000
CY2022Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
2200000
CY2023Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
5400000
CY2022Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
4500000
CY2023Q2 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
5600000
CY2022Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
4600000

Files In Submission

Name View Source Status
0001297184-23-000066-index-headers.html Edgar Link pending
0001297184-23-000066-index.html Edgar Link pending
0001297184-23-000066.txt Edgar Link pending
0001297184-23-000066-xbrl.zip Edgar Link pending
amph-20230630.xsd Edgar Link pending
amph-20230630x10q.htm Edgar Link pending
amph-20230630xex10d1.htm Edgar Link pending
amph-20230630xex10d2.htm Edgar Link pending
amph-20230630xex10d3.htm Edgar Link pending
amph-20230630xex10d4.htm Edgar Link pending
amph-20230630xex31d1.htm Edgar Link pending
amph-20230630xex31d2.htm Edgar Link pending
amph-20230630xex32d1.htm Edgar Link pending
amph-20230630xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
amph-20230630_cal.xml Edgar Link unprocessable
amph-20230630_def.xml Edgar Link unprocessable
amph-20230630_lab.xml Edgar Link unprocessable
amph-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
amph-20230630x10q_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending